Immune Thrombocytopenic Purpura
📧 Sign up to get email alerts when something new happens for Immune Thrombocytopenic Purpura.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2015-07-30Clinical Trial Update: MONICA-SC: A Study to Evaluate the Efficacy, Safety and Tolerability of Blisibimod (A-623) Administration in Subjects With ITP [Phase 2, Phase 3]
The MONICA-SC trial evaluating Blisibimod (A-623) for Immune Thrombocytopenic Purpura/Idiopathic Thrombocytopenic Purpura has been withdrawn…
-
CLINICAL_TRIALS trial_result · 2014-02-14Clinical Trial Update: Initial Treatment of Patients With Immune Thrombocytopenic Purpura [Phase 3]
A Phase 3 trial evaluating initial treatment for Immune Thrombocytopenic Purpura was terminated, with results posted in 2014.
-
CLINICAL_TRIALS trial_result · 2013-03-22Clinical Trial Update: Low-dose Rituximab and High-dose Dexamethasone as First Line Treatment for ITP [Phase 2]
A Phase 2 trial evaluating low-dose Rituximab combined with high-dose Dexamethasone as first-line therapy for Immune Thrombocytopenic Purpur…
-
CLINICAL_TRIALS trial_result · 2012-11-21Clinical Trial Update: Helicobacter Pylori Treatment in Immune Thrombocytopenic Purpura (ITP) Patients [Phase 2, Phase 3]
Phase 2/3 trial evaluating Helicobacter pylori eradication therapy in patients with immune thrombocytopenic purpura has completed. The updat…
-
CLINICAL_TRIALS trial_result · 2012-11-09Clinical Trial Update: Clinical Trial of Rituximab in Children and Adolescents With Chronic Idiopathic Thrombocytopenic Purpura (ITP) [Phase 1, Phase 2]
This clinical trial evaluated rituximab in children and adolescents with chronic idiopathic thrombocytopenic purpura (ITP) and has completed…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-06-25Clinical Trial Update: Outcomes Comparison of Chronic Immune Thrombocytopenic Purpura (ITP) Patients Switched to Eltrombopag and Romiplostim
This clinical trial update reports outcomes for chronic immune thrombocytopenic purpura patients switched to eltrombopag versus romiplostim.
-
CLINICAL_TRIALS trial_result · 2012-06-06Clinical Trial Update: A Study to Find How Safe and Effective GAMMAPLEX® is in Subjects With Chronic Idiopathic Thrombocytopenic Purpura (ITP) [Phase 3]
A Phase 3 trial evaluating the safety and effectiveness of GAMMAPLEX in chronic immune thrombocytopenic purpura has completed, with results …
-
CLINICAL_TRIALS research · 2010-12-07Clinical Trial Update: Helicobacter Pylori Immune Thrombocytopenic Purpura
A clinical trial update regarding Helicobacter pylori-associated immune thrombocytopenic purpura; the current trial status is unknown.
-
CLINICAL_TRIALS trial_result · 2008-09-10Clinical Trial Update: Phase II Study of High-Dose Cyclophosphamide in Patients With Severe Autoimmune Hematologic Disease [Phase 2]
A Phase II trial evaluated high-dose cyclophosphamide in patients with severe autoimmune hematologic disease. The study focused on autoimmun…